Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$3.22M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$1.9M$3.8M2025 · bought $0 · sold $3.8M20252026 · bought $0 · sold $1.5M2026
Total +$0.0000 bought · $5.34M sold

All filings on record

Every Form 4 transaction we track for this filer

IONSSell
2026-06-26 · IONIS PHARMACEUTICALS INC
$451.7K
IONSExercise
2026-06-26 · IONIS PHARMACEUTICALS INC
$57.7K
IONSExercise
2026-06-26 · IONIS PHARMACEUTICALS INC
$219.5K
IONSSell
2026-01-30 · IONIS PHARMACEUTICALS INC
$439.4K
IONSGrant
2026-01-29 · IONIS PHARMACEUTICALS INC
10,278
IONSSell
2026-01-16 · IONIS PHARMACEUTICALS INC
$87.1K
IONSSell
2026-01-16 · IONIS PHARMACEUTICALS INC
$523.2K
IONSExercise
2026-01-15 · IONIS PHARMACEUTICALS INC
2,850
IONSExercise
2026-01-15 · IONIS PHARMACEUTICALS INC
17,037
IONSSell
2025-10-06 · IONIS PHARMACEUTICALS INC
$112.7K
IONSSell
2025-10-02 · IONIS PHARMACEUTICALS INC
$1.02M
IONSExercise
2025-10-02 · IONIS PHARMACEUTICALS INC
$477.0K
IONSSell
2025-09-09 · IONIS PHARMACEUTICALS INC
$742.8K
IONSExercise
2025-09-09 · IONIS PHARMACEUTICALS INC
$380.0K
IONSSell
2025-09-05 · IONIS PHARMACEUTICALS INC
$15.5K
IONSExercise
2025-09-05 · IONIS PHARMACEUTICALS INC
$8.0K
IONSExercise
2025-09-03 · IONIS PHARMACEUTICALS INC
$477.0K
IONSSell
2025-09-03 · IONIS PHARMACEUTICALS INC
$1.77M
IONSExercise
2025-09-03 · IONIS PHARMACEUTICALS INC
$477.0K
IONSSell
2025-09-03 · IONIS PHARMACEUTICALS INC
$173.6K
IONSExercise
2025-09-03 · IONIS PHARMACEUTICALS INC
$89.0K

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.